Furthermore, NF1‐mutant melanomas have been found to be dependent on MAPK signaling and to respond to inhibitors targeting key players of this pathway (MEK, ERK) (Maertens et al., 2013; Nissan et al., 2014; Whittaker et al., 2013). Here, MAP2K7 is linked to melanoma.